Cumberland Pharmaceuticals Inc. Net Income (Loss) Attributable to Noncontrolling Interest
Cumberland Pharmaceuticals Inc. (CPIX) reported Net Income (Loss) Attributable to Noncontrolling Interest of $1.95 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Income Statement › Net Income
us-gaap:NetIncomeLossAttributableToNoncontrollingInterest · last filed 2026-08-07
- Cumberland Pharmaceuticals Inc. net income (loss) attributable to noncontrolling interest for the quarter ending 2026-06-30 was $1.95K, a 64.81% decline year-over-year.
- Cumberland Pharmaceuticals Inc. net income (loss) attributable to noncontrolling interest for the quarter ending 2026-03-31 was $2.59K.
- Cumberland Pharmaceuticals Inc. net income (loss) attributable to noncontrolling interest for the quarter ending 2025-12-31 was -$16.95K, a 878.59% decline year-over-year.
- Cumberland Pharmaceuticals Inc. net income (loss) attributable to noncontrolling interest for the quarter ending 2025-09-30 was -$8.28K, a 216.45% decline year-over-year.
- Cumberland Pharmaceuticals Inc. net income (loss) attributable to noncontrolling interest for fiscal 2025 was -$28.58K, a 179.28% decline from fiscal 2024.
- Cumberland Pharmaceuticals Inc. net income (loss) attributable to noncontrolling interest for fiscal 2024 was $36.05K.
- Cumberland Pharmaceuticals Inc. net income (loss) attributable to noncontrolling interest for fiscal 2023 was -$51.45K.
- Cumberland Pharmaceuticals Inc. net income (loss) attributable to noncontrolling interest for fiscal 2022 was -$79.80K.
| Period end | Net Income (Loss) Attributable to Noncontrolling Interest 3 month | Net Income (Loss) Attributable to Noncontrolling Interest 3 month as first filed | Net Income (Loss) Attributable to Noncontrolling Interest 6 month | Net Income (Loss) Attributable to Noncontrolling Interest 9 month | Net Income (Loss) Attributable to Noncontrolling Interest 12 month |
|---|---|---|---|---|---|
| 2026-06-30 | $1.95K 10-Q · filed 2026-08-07 | $4.54K 10-Q · filed 2026-08-07 | -$12.41K derived: sum of 3 quarters · filed 2026-08-07 | -$20.70K derived: sum of 4 quarters · filed 2026-08-07 | |
| 2026-03-31 | $2.59K 10-Q · filed 2026-05-08 | -$14.36K derived: sum of 2 quarters · filed 2026-05-08 | -$22.64K derived: sum of 3 quarters · filed 2026-05-08 | -$17.11K derived: sum of 4 quarters · filed 2026-08-07 | |
| 2025-12-31 | -$16.95K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-09 | -$25.23K derived: sum of 2 quarters · filed 2026-03-09 | -$19.70K derived: sum of 3 quarters · filed 2026-08-07 | -$28.58K 10-K · filed 2026-03-09 | |
| 2025-09-30 | -$8.28K 10-Q · filed 2025-11-07 | -$2.75K derived: sum of 2 quarters · filed 2026-08-07 | -$11.63K 10-Q · filed 2025-11-07 | -$9.46K derived: sum of 4 quarters · filed 2026-08-07 | |
| 2025-06-30 | $5.53K 10-Q · filed 2026-08-07 | -$3.35K 10-Q · filed 2026-08-07 | -$1.17K derived: sum of 3 quarters · filed 2026-08-07 | $5.94K derived: sum of 4 quarters · filed 2026-08-07 | |
| 2025-03-31 | -$8.88K 10-Q · filed 2026-05-08 | -$6.71K derived: sum of 2 quarters · filed 2026-05-08 | $405.00 derived: sum of 3 quarters · filed 2026-05-08 | -$16.62K derived: sum of 4 quarters · filed 2026-05-08 | |
| 2024-12-31 | $2.18K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-09 | $9.29K derived: sum of 2 quarters · filed 2026-03-09 | -$7.74K derived: sum of 3 quarters · filed 2026-03-09 | $36.05K 10-K · filed 2026-03-09 | |
| 2024-09-30 | $7.11K 10-Q · filed 2025-11-07 | -$9.91K derived: sum of 2 quarters · filed 2025-11-07 | $33.88K 10-Q · filed 2025-11-07 | $26.30K derived: sum of 4 quarters · filed 2025-11-07 | |
| 2024-06-30 | -$17.02K 10-Q · filed 2025-08-08 | $26.77K 10-Q · filed 2025-08-08 | $19.18K derived: sum of 3 quarters · filed 2025-08-08 | $5.26K derived: sum of 4 quarters · filed 2025-08-08 | |
| 2024-03-31 | $43.79K 10-Q · filed 2025-05-09 | $36.21K derived: sum of 2 quarters · filed 2025-05-09 | $22.29K derived: sum of 3 quarters · filed 2025-05-09 | $12.24K derived: sum of 4 quarters · filed 2025-05-09 | |
| 2023-12-31 | -$7.58K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-07 | -$21.50K derived: sum of 2 quarters · filed 2025-03-07 | -$31.55K derived: sum of 3 quarters · filed 2025-03-07 | -$51.45K 10-K · filed 2025-03-07 | |
| 2023-09-30 | -$13.92K 10-Q · filed 2024-11-08 | -$23.97K derived: sum of 2 quarters · filed 2024-11-08 | -$43.87K 10-Q · filed 2024-11-08 | -$62.85K derived: sum of 4 quarters · filed 2024-11-08 | |
| 2023-06-30 | -$10.05K 10-Q · filed 2024-08-09 | -$29.94K 10-Q · filed 2024-08-09 | -$48.93K derived: sum of 3 quarters · filed 2024-08-09 | -$63.52K derived: sum of 4 quarters · filed 2024-08-09 | |
| 2023-03-31 | -$19.90K 10-Q · filed 2024-05-10 | -$38.88K derived: sum of 2 quarters · filed 2024-05-10 | -$53.47K derived: sum of 3 quarters · filed 2024-05-10 | -$82.52K derived: sum of 4 quarters · filed 2024-05-10 | |
| 2022-12-31 | -$18.98K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-13 | -$33.57K derived: sum of 2 quarters · filed 2024-03-13 | -$62.62K derived: sum of 3 quarters · filed 2024-03-13 | -$79.80K 10-K · filed 2024-03-13 | |
| 2022-09-30 | -$14.59K 10-Q · filed 2023-11-13 | -$43.63K derived: sum of 2 quarters · filed 2023-11-13 | -$60.81K 10-Q · filed 2023-11-13 | -$97.37K derived: sum of 4 quarters · filed 2023-11-13 | |
| 2022-06-30 | -$29.05K 10-Q · filed 2023-08-11 | -$46.23K 10-Q · filed 2023-08-11 | -$82.79K derived: sum of 3 quarters · filed 2023-08-11 | -$114.20K derived: sum of 4 quarters · filed 2023-08-11 | |
| 2022-03-31 | -$17.18K 10-Q · filed 2023-05-12 | -$53.74K derived: sum of 2 quarters · filed 2023-05-12 | -$85.16K derived: sum of 3 quarters · filed 2023-05-12 | -$90.22K derived: sum of 4 quarters · filed 2023-05-12 | |
| 2021-12-31 | -$36.56K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-13 | -$67.98K derived: sum of 2 quarters · filed 2023-03-13 | -$73.05K derived: sum of 3 quarters · filed 2023-03-13 | -$95.21K 10-K · filed 2023-03-13 | |
| 2021-09-30 | -$31.41K 10-Q · filed 2022-11-14 | -$36.48K derived: sum of 2 quarters · filed 2022-11-14 | -$58.65K 10-Q · filed 2022-11-14 | -$90.34K derived: sum of 4 quarters · filed 2022-11-14 | |
| 2021-06-30 | -$5.07K 10-Q · filed 2022-08-12 | -$27.24K 10-Q · filed 2022-08-12 | -$58.93K derived: sum of 3 quarters · filed 2022-08-12 | -$74.89K derived: sum of 4 quarters · filed 2022-08-12 | |
| 2021-03-31 | -$22.17K 10-Q · filed 2022-05-13 | -$53.86K derived: sum of 2 quarters · filed 2022-05-13 | -$69.82K derived: sum of 3 quarters · filed 2022-05-13 | -$92.14K derived: sum of 4 quarters · filed 2022-05-13 | |
| 2020-12-31 | -$31.69K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-11 | -$47.66K derived: sum of 2 quarters · filed 2022-03-11 | -$69.97K derived: sum of 3 quarters · filed 2022-03-11 | -$79.50K 10-K · filed 2022-03-11 | |
| 2020-09-30 | -$15.97K 10-Q · filed 2021-11-12 | -$38.28K derived: sum of 2 quarters · filed 2021-11-12 | -$47.81K 10-Q · filed 2021-11-12 | -$59.45K derived: sum of 4 quarters · filed 2022-03-11 | |
| 2020-06-30 | -$22.31K 10-Q · filed 2021-08-13 | -$31.84K 10-Q · filed 2021-08-13 | -$43.48K derived: sum of 3 quarters · filed 2022-03-11 | -$56.75K derived: sum of 4 quarters · filed 2022-03-11 | |
| 2020-03-31 | -$9.53K 10-Q · filed 2021-05-14 | -$21.16K derived: sum of 2 quarters · filed 2022-03-11 | -$34.43K derived: sum of 3 quarters · filed 2022-03-11 | -$51.74K derived: sum of 4 quarters · filed 2022-03-11 | |
| 2019-12-31 | -$11.64K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-11 | -$24.91K derived: sum of 2 quarters · filed 2022-03-11 | -$42.21K derived: sum of 3 quarters · filed 2022-03-11 | -$8.75K 10-K · filed 2022-03-11 | |
| 2019-09-30 | -$13.27K 10-Q · filed 2020-11-13 | -$30.57K derived: sum of 2 quarters · filed 2020-11-13 | $2.89K 10-Q · filed 2020-11-13 | -$14.13K derived: sum of 4 quarters · filed 2021-03-12 | |
| 2019-06-30 | -$17.30K 10-Q · filed 2020-08-14 | $16.16K 10-Q · filed 2020-08-14 | -$860.00 derived: sum of 3 quarters · filed 2021-03-12 | -$21.84K derived: sum of 4 quarters · filed 2021-03-12 | |
| 2019-03-31 | $33.46K 10-Q · filed 2020-05-22 | $16.45K derived: sum of 2 quarters · filed 2021-03-12 | -$4.53K derived: sum of 3 quarters · filed 2021-03-12 | -$29.29K derived: sum of 4 quarters · filed 2021-03-12 | |
| 2018-12-31 | -$17.02K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-12 | -$37.99K derived: sum of 2 quarters · filed 2021-03-12 | -$62.75K derived: sum of 3 quarters · filed 2021-03-12 | -$75.70K 10-K · filed 2021-03-12 | |
| 2018-09-30 | -$20.98K 10-Q · filed 2019-11-13 | -$45.74K derived: sum of 2 quarters · filed 2019-11-13 | -$58.69K 10-Q · filed 2019-11-13 | -$79.95K derived: sum of 4 quarters · filed 2020-12-10 | |
| 2018-06-30 | -$24.76K 10-Q · filed 2019-08-14 | -$37.71K 10-Q · filed 2019-08-14 | -$58.97K derived: sum of 3 quarters · filed 2020-12-10 | -$73.18K derived: sum of 4 quarters · filed 2020-12-10 | |
| 2018-03-31 | -$12.95K 10-Q · filed 2019-05-15 | $12.95K 10-Q · filed 2018-05-09 | -$34.21K derived: sum of 2 quarters · filed 2020-12-10 | -$48.42K derived: sum of 3 quarters · filed 2020-12-10 | -$65.01K derived: sum of 4 quarters · filed 2020-12-10 |
| 2017-12-31 | -$21.26K derived: 8-K 12 month − 10-Q 9 month · filed 2020-12-10 | -$35.47K derived: sum of 2 quarters · filed 2020-12-10 | -$52.06K derived: sum of 3 quarters · filed 2020-12-10 | -$71.18K 8-K · filed 2020-12-10 | |
| 2017-09-30 | -$14.21K 10-Q · filed 2018-11-14 | -$30.80K derived: sum of 2 quarters · filed 2018-11-14 | -$49.92K 10-Q · filed 2018-11-14 | -$31.91K derived: sum of 4 quarters · filed 2019-03-12 | |
| 2017-06-30 | -$16.59K 10-Q · filed 2018-08-14 | -$35.71K 10-Q · filed 2018-08-14 | -$17.70K derived: sum of 3 quarters · filed 2019-03-12 | -$28.38K derived: sum of 4 quarters · filed 2019-03-12 | |
| 2017-03-31 | $19.12K 10-Q · filed 2018-05-09 | -$19.12K 10-Q · filed 2017-05-15 | -$1.11K derived: sum of 2 quarters · filed 2019-03-12 | -$11.79K derived: sum of 3 quarters · filed 2019-03-12 | -$24.69K derived: sum of 4 quarters · filed 2019-03-12 |
| 2016-12-31 | -$20.24K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-12 | -$30.91K derived: sum of 2 quarters · filed 2019-03-12 | -$43.81K derived: sum of 3 quarters · filed 2019-03-12 | -$59.26K 10-K · filed 2019-03-12 | |
| 2016-09-30 | -$10.68K 10-Q · filed 2017-11-08 | -$23.57K derived: sum of 2 quarters · filed 2017-11-08 | -$39.02K 10-Q · filed 2017-11-08 | -$61.48K derived: sum of 4 quarters · filed 2018-03-09 | |
| 2016-06-30 | -$12.89K 10-Q · filed 2017-08-09 | -$28.34K 10-Q · filed 2017-08-09 | -$50.80K derived: sum of 3 quarters · filed 2018-03-09 | -$55.71K derived: sum of 4 quarters · filed 2018-03-09 | |
| 2016-03-31 | -$15.45K 10-Q · filed 2017-05-15 | -$37.91K derived: sum of 2 quarters · filed 2018-03-09 | -$42.82K derived: sum of 3 quarters · filed 2018-03-09 | -$54.52K derived: sum of 4 quarters · filed 2018-03-09 | |
| 2015-12-31 | -$22.46K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-09 | -$27.37K derived: sum of 2 quarters · filed 2018-03-09 | -$39.07K derived: sum of 3 quarters · filed 2018-03-09 | -$60.24K 10-K · filed 2018-03-09 | |
| 2015-09-30 | -$4.91K 10-Q · filed 2016-11-03 | -$16.61K derived: sum of 2 quarters · filed 2016-11-03 | -$37.78K 10-Q · filed 2016-11-03 | -$56.73K derived: sum of 4 quarters · filed 2017-03-13 | |
| 2015-06-30 | -$11.70K 10-Q · filed 2016-08-05 | -$31.47K 10-Q · filed 2016-08-05 | -$51.82K derived: sum of 3 quarters · filed 2017-03-13 | -$68.56K derived: sum of 4 quarters · filed 2017-03-13 | |
| 2015-03-31 | -$19.77K 10-Q · filed 2016-05-13 | -$40.12K derived: sum of 2 quarters · filed 2017-03-13 | -$56.85K derived: sum of 3 quarters · filed 2017-03-13 | -$69.89K derived: sum of 4 quarters · filed 2017-03-13 | |
| 2014-12-31 | -$20.35K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-13 | -$37.09K derived: sum of 2 quarters · filed 2017-03-13 | -$50.12K derived: sum of 3 quarters · filed 2017-03-13 | -$61.26K 10-K · filed 2017-03-13 | |
| 2014-09-30 | -$16.74K 10-Q · filed 2015-11-06 | -$29.77K derived: sum of 2 quarters · filed 2015-11-06 | -$40.91K 10-Q · filed 2015-11-06 | -$51.94K derived: sum of 4 quarters · filed 2016-03-14 | |
| 2014-06-30 | -$13.03K 10-Q · filed 2015-08-07 | -$24.17K 10-Q · filed 2015-08-07 | -$35.20K derived: sum of 3 quarters · filed 2016-03-14 | -$47.76K derived: sum of 4 quarters · filed 2016-03-14 | |
| 2014-03-31 | -$11.14K 10-Q · filed 2015-05-15 | -$22.17K derived: sum of 2 quarters · filed 2016-03-14 | -$34.72K derived: sum of 3 quarters · filed 2016-03-14 | -$44.56K derived: sum of 4 quarters · filed 2016-03-14 | |
| 2013-12-31 | -$11.03K derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-14 | -$23.59K derived: sum of 2 quarters · filed 2016-03-14 | -$33.42K derived: sum of 3 quarters · filed 2016-03-14 | -$46.80K 10-K · filed 2016-03-14 | |
| 2013-09-30 | -$12.55K 10-Q · filed 2014-11-07 | -$22.39K derived: sum of 2 quarters · filed 2014-11-07 | -$35.77K 10-Q · filed 2014-11-07 | -$47.32K derived: sum of 4 quarters · filed 2015-03-09 | |
| 2013-06-30 | -$9.84K 10-Q · filed 2014-08-08 | -$23.22K 10-Q · filed 2014-08-08 | -$34.76K derived: sum of 3 quarters · filed 2015-03-09 | -$42.10K derived: sum of 4 quarters · filed 2015-03-09 | |
| 2013-03-31 | -$13.38K 10-Q · filed 2014-05-12 | -$24.93K derived: sum of 2 quarters · filed 2015-03-09 | -$32.27K derived: sum of 3 quarters · filed 2015-03-09 | -$40.30K derived: sum of 4 quarters · filed 2015-03-09 | |
| 2012-12-31 | -$11.54K derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-09 | -$18.88K derived: sum of 2 quarters · filed 2015-03-09 | -$26.92K derived: sum of 3 quarters · filed 2015-03-09 | -$36.29K 10-K · filed 2015-03-09 | |
| 2012-09-30 | -$7.34K 10-Q · filed 2013-11-06 | -$15.37K derived: sum of 2 quarters · filed 2013-11-06 | -$24.74K 10-Q · filed 2013-11-06 | -$28.28K derived: sum of 4 quarters · filed 2014-03-11 | |
| 2012-06-30 | -$8.04K 10-Q · filed 2013-08-09 | -$17.40K 10-Q · filed 2013-08-09 | -$20.94K derived: sum of 3 quarters · filed 2014-03-11 | -$29.40K derived: sum of 4 quarters · filed 2014-03-11 | |
| 2012-03-31 | -$9.37K 10-Q · filed 2013-05-08 | -$12.91K derived: sum of 2 quarters · filed 2014-03-11 | -$21.36K derived: sum of 3 quarters · filed 2014-03-11 | -$30.83K derived: sum of 4 quarters · filed 2014-03-11 | |
| 2011-12-31 | -$3.54K derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-11 | -$11.99K derived: sum of 2 quarters · filed 2014-03-11 | -$21.47K derived: sum of 3 quarters · filed 2014-03-11 | -$31.34K 10-K · filed 2014-03-11 | |
| 2011-09-30 | -$8.46K 10-Q · filed 2012-11-02 | -$17.93K derived: sum of 2 quarters · filed 2012-11-02 | -$27.80K 10-Q · filed 2012-11-02 | -$33.22K derived: sum of 4 quarters · filed 2013-03-12 | |
| 2011-06-30 | -$9.47K 10-Q · filed 2012-08-09 | -$19.35K 10-Q · filed 2012-08-09 | -$24.76K derived: sum of 3 quarters · filed 2013-03-12 | -$31.41K derived: sum of 4 quarters · filed 2013-03-12 | |
| 2011-03-31 | -$9.88K 10-Q · filed 2012-05-04 | -$15.29K derived: sum of 2 quarters · filed 2013-03-12 | -$21.94K derived: sum of 3 quarters · filed 2013-03-12 | -$29.47K derived: sum of 4 quarters · filed 2013-03-12 | |
| 2010-12-31 | -$5.41K derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-12 | -$12.06K derived: sum of 2 quarters · filed 2013-03-12 | -$19.59K derived: sum of 3 quarters · filed 2013-03-12 | -$29.67K 10-K · filed 2013-03-12 | |
| 2010-09-30 | -$6.65K 10-Q · filed 2011-11-07 | -$14.18K derived: sum of 2 quarters · filed 2011-11-07 | -$24.25K 10-Q · filed 2011-11-07 | ||
| 2010-06-30 | -$7.53K 10-Q · filed 2011-08-08 | -$17.61K 10-Q · filed 2011-08-08 | |||
| 2009-12-31 | -$32.54K 10-K · filed 2012-03-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aardvark Therapeutics, Inc. (AARD) | United States | $0.121B | -1.80 |
| Coya Therapeutics, Inc. (COYA) | United States | $0.121B | -6.35 |
| OnKure Therapeutics, Inc. (OKUR) | United States | $0.119B | -3.13 |
| INOVIO PHARMACEUTICALS, INC. (INO) | United States | $0.125B | -1.35 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |
| Immuneering Corp (IMRX) | United States | $0.113B | -12.51 |
| Quantum Cyber N.V. (QUCY) | $0.113B | ||
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| BICYCLE THERAPEUTICS PLC (BCYC) | $0.112B | -1.56 | |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |